Jump to content

FG-5893

From Wikipedia, the free encyclopedia
FG-5893
Clinical data
Other namesFG5893
Identifiers
  • methyl 2-[4-[4,4-bis(4-fluorophenyl)butyl]piperazin-1-yl]pyridine-3-carboxylate
CAS Number
PubChem CID
IUPHAR/BPS
ChemSpider
UNII
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC27H29F2N3O3
Molar mass481.544 g·mol−1
3D model (JSmol)
  • COC(=O)C1=C(N=CC=C1)N2CCN(CC2)CCCC(C3=CC=C(C=C3)F)C4=CC=C(C=C4)F
  • InChI=1S/C27H29F2N3O2/c1-34-27(33)25-4-2-14-30-26(25)32-18-16-31(17-19-32)15-3-5-24(20-6-10-22(28)11-7-20)21-8-12-23(29)13-9-21/h2,4,6-14,24H,3,5,15-19H2,1H3
  • Key:NDCPNKXUTJGQQC-UHFFFAOYSA-N

FG-5893 is a chemical from the diphenylbutylpiperazine class of agents. It is a 5-HT1A agonist and a 5-HT2A antagonist.[1]

It is believed to be an anxiolytic agent with potential uses in the treatment of substance abuse disorders particularly alcoholism.[2][3][4]

There is evidence for FG-5893 behaving as a SNDRI:[5]

See also

[edit]

References

[edit]
  1. ^ Myers RD (1994). "New drugs for the treatment of experimental alcoholism". review. Alcohol. 11 (6). Fayetteville, N.Y.: 439–451. doi:10.1016/0741-8329(94)90064-7. PMID 7865140.
  2. ^ Albinsson A, Björk A, Svartengren J, Klint T, Andersson G (August 1994). "Preclinical pharmacology of FG5893: a potential anxiolytic drug with high affinity for both 5-HT1A and 5-HT2A receptors". European Journal of Pharmacology. 261 (3): 285–94. doi:10.1016/0014-2999(94)90119-8. PMID 7813550.
  3. ^ Lankford MF, Björk AK, Myers RD (1996). "Differential efficacy of serotonergic drugs FG5974, FG5893, and amperozide in reducing alcohol drinking in P rats". Alcohol (Fayetteville, N.Y.). 13 (4): 399–404. doi:10.1016/0741-8329(96)00061-4. PMID 8836330.
  4. ^ Long TA, Kalmus GW, Björk A, Myers RD (January 1996). "Alcohol intake in high alcohol drinking (HAD) rats is suppressed by FG5865, a novel 5-HT1A agonist/5-HT2 antagonist". Pharmacology, Biochemistry, and Behavior. 53 (1): 33–40. doi:10.1016/0091-3057(95)00195-6. PMID 8848457.
  5. ^ Pettersson, E. (August 1995). "Studies of four novel diphenylbutylpiperazinepyridyl derivatives on release and inhibition of reuptake of dopamine, serotonin and noradrenaline by rat brain in vitro". European Journal of Pharmacology. 282 (1–3): 131–135. doi:10.1016/0014-2999(95)00300-A.